Literature DB >> 14505282

Ebola hemorrhagic fever in the era of bioterrorism.

Andrea Polesky1, Gulshan Bhatia.   

Abstract

Viral hemorrhagic fevers are among a small group of infectious diseases considered potential candidates for use as agents of bioterrorism. Ebola hemorrhagic fever, the focus of this article, has the highest mortality rate of the viral hemorrhagic fevers and has no effective treatment. It is transmitted easily to family members and health care professionals not following universal precautions. The history of this infection, its clinical presentation, and epidemiology are discussed. Attention is paid to the immunopathogenesis of the disease with a focus on pulmonary involvement. Recommendations for infection control and Ebola virus' potential as a bioterrorism agent are addressed.

Entities:  

Mesh:

Year:  2003        PMID: 14505282

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  5 in total

1.  Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines.

Authors:  Ernest L Levroney; Hector C Aguilar; Jennifer A Fulcher; Luciana Kohatsu; Karen E Pace; Mabel Pang; Kevin B Gurney; Linda G Baum; Benhur Lee
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

2.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

3.  Material proximities and hotspots: toward an anthropology of viral hemorrhagic fevers.

Authors:  Hannah Brown; Ann H Kelly
Journal:  Med Anthropol Q       Date:  2014-04-21

Review 4.  Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic.

Authors:  Morenike O Folayan; Bridget G Haire; Brandon Brown
Journal:  Risk Manag Healthc Policy       Date:  2016-05-12

5.  Ebola vaccine development plan: ethics, concerns and proposed measures.

Authors:  Morenike Oluwatoyin Folayan; Aminu Yakubu; Bridget Haire; Kristin Peterson
Journal:  BMC Med Ethics       Date:  2016-02-08       Impact factor: 2.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.